The IT services corporation Wipro has announced that its senior vice-president and global head of the healthcare business Jeffrey Heenan-Jalil has stepped down after working for a decade with the company.
This resignation marked the second top-level exit in the healthcare division in less than three years. When Jalil joined Wipro, he succeeded Sangita Singh who later moved to Infosys and then to IBM’s global business services (GBS) division.
The customer list of Wipro counts Johnson& Johnson, Novartis and GE Healthcare. It has witnessed major challenges in its healthcare business following the acquisition of US company HealthPlan Services (HPS) for $460 million in 2016.
The company further also stated that Mohd Ehteshamul Haque, SVP and vertical head for healthcare and services, has replaced Heenan-Jalil as interim head of the healthcare unit.
The scrapping of ObamaCare by the Trump government hit Wipro hard as it had acquired HPS in anticipation of an increase in healthcare business once it was rolled out, as stated by Hansa Iyengar, CEO of London-based Ovum Research.
“Wipro has since restructured its healthcare business and has been winning contracts steadily over the last 12 months or so, and is slowly making up for the losses it suffered over the past couple of years. Wipro wasn’t the only one hit by this move, and other vendors also saw their healthcare business impacted negatively,” Hansa Iyengar said.
Prior to this, Heenan-Jalil led the position of global head of analytics service line, advanced technologies group. Before that he headed the telecom equipment vendor business. He started working with Wipro in 2007 to head the manufacturing, pharmaceutical and healthcare division for Europe.